Funding for this research was provided by:
Sheba Multiple Sclerosis Center (RA-2801/2020.)
Received: 15 December 2021
Revised: 13 February 2022
Accepted: 14 February 2022
First Online: 2 March 2022
: On behalf of all the authors, the corresponding author states that there is no conflict of interest.
: The study was approved by Sheba Medical Center Institutional Review Board [Sheba.SMC-8182-02], and all participants signed written informed consent. Each patient record was coded anonymously to ensure confidentiality during statistical analyses.
Free to read: This content has been made available to all.